Ethyl orthoformate → Ro 14-7437

HRID 67318

Reaktionsgleichung

Reaktionsgleichung von HRID 67318
[NH2:1][C:2](=[C:8]1[CH2:14][N:13]([CH3:15])[C:12](=[O:16])[C:11]2[CH:17]=[CH:18][CH:19]=[CH:20][C:10]=2[NH:9]1)[C:3]([O:5][CH2:6][CH3:7])=[O:4].[CH:21](OCC)(OCC)OCC>C1(C)C=CC=CC=1>[CH3:15][N:13]1[C:12](=[O:16])[C:11]2[CH:17]=[CH:18][CH:19]=[CH:20][C:10]=2[N:9]2[CH:21]=[N:1][C:2]([C:3]([O:5][CH2:6][CH3:7])=[O:4])=[C:8]2[CH2:14]1

Komponenten

4

Edukt 2

HCID 31214Ethyl orthoformateHCID 70541641ethyl alpha-amino-1,3,4,5-tetrahydro-4-methyl-5-oxo-2H-1,4-benzodiazepin-2-ylidene-acetate

Produkt 1

HCID 127597Ro 14-7437

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 1140TolueneLösungsmittel

Versuchsvorschrift

1.10 g of ethyl α-amino-1,3,4,5-tetrahydro-4-methyl-5-oxo-2H-1,4-benzodiazepin-2-ylidene-acetate are dissolved in 15 ml of toluene and treated with 1.0 ml of triethyl orthoformate. The mixture is heated to reflux for 50 minutes, subsequently cooled and evaporated in vacuo. The crystalline residue is suspended in 25 ml of ethyl acetate, filtered off and dried. There is obtained ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate of melting point 165° C.

Aufarbeitung

  1. temperatureThe mixture is heated
  2. temperatureto reflux for 50 minutes
  3. temperaturesubsequently cooled
  4. customevaporated in vacuo
  5. filtrationfiltered off
  6. customdried

Quellen und Nachweise

ORD-Eintrag
ord-6282bb24c0b34c5584d9bba722813b52
Quelldatensatz
uspto-grants-1982_08
Patentnummer
US04346030

Verknüpfte Notizen

Wird geladen…